SCHEMBL8505693

SCHEMBL8505693

CN1CCc2c(ccc(O)c2O)C(c2cccc3ccoc23)C1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 14/20 0.66
SLC6A2 P23975 2/20 0.57
SLC6A4 P31645 2/20 0.57
SLC6A3 Q01959 2/20 0.57
DRD2 P14416 8/20 0.41
HTR2A P28223 4/20 0.41
CYP2D6 P10635 2/20 0.41
TSHR P16473 2/20 0.41
THPO P40225 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
HIF1A Q16665 1/20 0.41
KDM4E B2RXH2 4/20 0.40
MAPT P10636 3/20 0.40
PMP22 Q01453 3/20 0.40
ADRA2A P08913 2/20 0.40
MTOR P42345 1/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8504189 0.88 SLC6A2 (0.62) DRD1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL8504083 0.82 SLC6A2 (0.58) DRD1SLC6A2SLC6A4SLC6A3DRD5
SCHEMBL8504160 0.80 DRD1 (0.53) DRD1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL8504024 0.80 DRD1 (0.53) DRD1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL29602922 0.79 DRD1 (1.00) DRD1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL29507713 0.79 DRD1 (1.00) DRD1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL5138043 0.79 DRD1 (1.00) DRD1SLC6A2SLC6A4SLC6A3DRD2
Hydrochloric Acid SCHEMBL7267588 0.76 DRD1 (0.52) DRD1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL4308075 0.75 SLC6A2 (0.67) DRD1SLC6A2SLC6A4SLC6A3HTR2A
SCHEMBL8506306 0.74 DRD1 (0.42) DRD1DRD2HTR2ACYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0688320-B1 TRICYCLIC BENZODIAZEPINS, THEIR USE AND PREPARATION NOVO NORDISK AS (DK) 1999-05-06 EP disclosed
US-5512562-A FOR CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOSIS, DEPRESSION, SLEEP DISORDERS, PARKINSON*S DISEASE, STROKE NOVO NORDISK A/S (DK) 1996-04-30 US disclosed
EP-0688320-A1 TRICYCLIC BENZODIAZEPINS, THEIR USE AND PREPARATION NOVO NORDISK A/S (DK) 1995-12-27 EP disclosed
WO-1994020472-A1 HETEROCYCLIC COMPOUNDS, THEIR USE AND PREPARATION NOVO NORDISK A/S (DK) 1994-09-15 WO disclosed